About Xbiotech (XBIT)
XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies for treating a variety of diseases, such as cancer, vascular disease, inflammatory skin disease, and diabetes.
- USD2.99
- USD3.24
- USD2.99
- USD8.32
- 4.20%
- --
- 56.79k
- 135.03k
- 85M
- 2.50
- -42.20%
Stock News
yesterday
An upgrade for Apple’s stock? It’s not the endorsement you might think.
MarketWatch
yesterday
Jim Cramer explains how Microsoft, Meta and Nvidia led the Mag 7 pack in the first half of 2025
CNBC
yesterday
Bank of America Comments on Stress Test Results; Plans to Increase Quarterly Dividend 8% to $0.28 Per Share
Yahoo
yesterday
Mark Zuckerberg's costly AI talent push has not cost Meta stock yet. Here's why
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
